Skip to content

Clinical trials

Phase 3 Digestive System Diseases trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Digestive System Diseases Phase: Phase 3 Country / region: Japan Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20163
20202
20222
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
Sumitomo Pharma America, Inc.2
89bio, Inc.1
Abbott1
AstraZeneca1
Celgene1
Gilead Sciences1
National Cancer Center Hospital East1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Digestive System Diseases10
Gastrointestinal Diseases6
Digestive System Neoplasms5
Colorectal Neoplasms4
Gastrointestinal Neoplasms4
Intestinal Diseases4
Neoplasms4
Neoplasms by Site4
Colonic Diseases3
Intestinal Neoplasms3

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.